← Every company
Emergent BioSolutions Inc SEC Filings
What Emergent BioSolutions Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
EBS overview →Filings on file
174
since Sep 30, 2016
Warning signs
3
latest Nov 24, 2023
Last results
Aug 5, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| May 15, 2023 | Acquisition or sale completed 8-K | Read ↗ |
| Sep 26, 2022 | Acquisition or sale completed 8-K | Read ↗ |
| Oct 15, 2018 | Acquisition or sale completedNew debtUnregistered share sale 8-K | Read ↗ |
| Oct 5, 2018 | Acquisition or sale completedNew debt 8-K | Read ↗ |
| Oct 6, 2017 | Acquisition or sale completed 8-K | Read ↗ |
| Oct 3, 2017 | Acquisition or sale completed 8-K | Read ↗ |
Source: Emergent BioSolutions Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on EBS
Company overviewEverything on EBS in one place, with the price.Insider tradingWhat EBS's own officers and directors buy and sell.Planned salesSales EBS insiders have filed notice of.Who owns itEvery manager reporting a position in EBS.Funds holding itWhich funds and ETFs hold EBS, and how big a bet.LobbyingWhat EBS spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on EBS's account, and who they worked for.Federal contractsWhat federal agencies pay EBS.